Literature DB >> 8628649

Characterization of the AB (AF-1) region in the muscle-specific retinoid X receptor-gamma: evidence that the AF-1 region functions in a cell-specific manner.

D H Dowhan1, G E Muscat.   

Abstract

The retinoid X receptors alpha, beta and gamma (RXRs) share a highly conserved 'C' region or DNA binding domain (DBD). The conserved 'DE' region or ligand binding domain (LBD) of the RXRs is functionally complex, mediating dimerization and a ligand-dependent activation function (AF-2). The AB or N-terminal region of the RXRs is poorly conserved and encodes a ligand-independent activation function (AF-1). RXR gamma mRNA is preferentially expressed in skeletal and cardiac muscle, however, cell-specific steroid receptor-mediated trans-activation is a poorly understood phenomenon. We utilized the GAL4 hybrid assay system and have demonstrated that RXR gamma contains two functional domains in the AB and DE regions that activate transcription in a ligand-independent and -dependent manner respectively. The functions of the AB (AF-1) and DE (AF-2) domains were regulated by cAMP-dependent protein kinases, furthermore, the function of AF-2 in the LBD was activated by 8-Br-cAMP, independent of 9-cis-retinoic acid treatment. Deletion analysis demonstrated that the AF-1 of RXR gamma, is located between amino acids 1 and 103 and contained multiple motifs that were targets of cAMP-dependent protein kinases. Transfection analyses in non-muscle and myogenic cells clearly demonstrated that: (i) the AF-1 of RXR gamma functions in a muscle-specific manner and is required for optimal ligand-dependent trans-activation from an RXRE; (ii) RXR gamma trans-activates more efficiently in a myogenic background.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8628649      PMCID: PMC145623          DOI: 10.1093/nar/24.2.264

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  37 in total

1.  An amino-terminal c-myc domain required for neoplastic transformation activates transcription.

Authors:  G J Kato; J Barrett; M Villa-Garcia; C V Dang
Journal:  Mol Cell Biol       Date:  1990-11       Impact factor: 4.272

Review 2.  Phosphorylation of steroid hormone receptors.

Authors:  E Ortí; J E Bodwell; A Munck
Journal:  Endocr Rev       Date:  1992-02       Impact factor: 19.871

Review 3.  Interactions among a subfamily of nuclear hormone receptors: the regulatory zipper model.

Authors:  B M Forman; H H Samuels
Journal:  Mol Endocrinol       Date:  1990-09

Review 4.  Retinoids and their receptors in differentiation, embryogenesis, and neoplasia.

Authors:  L M De Luca
Journal:  FASEB J       Date:  1991-11       Impact factor: 5.191

Review 5.  Multiplicity generates diversity in the retinoic acid signalling pathways.

Authors:  M Leid; P Kastner; P Chambon
Journal:  Trends Biochem Sci       Date:  1992-10       Impact factor: 13.807

6.  Promoter context- and response element-dependent specificity of the transcriptional activation and modulating functions of retinoic acid receptors.

Authors:  S Nagpal; M Saunders; P Kastner; B Durand; H Nakshatri; P Chambon
Journal:  Cell       Date:  1992-09-18       Impact factor: 41.582

7.  Immunodetection of multiple species of retinoic acid receptor alpha: evidence for phosphorylation.

Authors:  M P Gaub; C Rochette-Egly; Y Lutz; S Ali; H Matthes; I Scheuer; P Chambon
Journal:  Exp Cell Res       Date:  1992-08       Impact factor: 3.905

8.  Multiple parameters control the selectivity of nuclear receptors for their response elements. Selectivity and promiscuity in response element recognition by retinoic acid receptors and retinoid X receptors.

Authors:  S Mader; P Leroy; J Y Chen; P Chambon
Journal:  J Biol Chem       Date:  1993-01-05       Impact factor: 5.157

9.  Characterization of three RXR genes that mediate the action of 9-cis retinoic acid.

Authors:  D J Mangelsdorf; U Borgmeyer; R A Heyman; J Y Zhou; E S Ong; A E Oro; A Kakizuka; R M Evans
Journal:  Genes Dev       Date:  1992-03       Impact factor: 11.361

10.  Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently.

Authors:  M Leid; P Kastner; R Lyons; H Nakshatri; M Saunders; T Zacharewski; J Y Chen; A Staub; J M Garnier; S Mader
Journal:  Cell       Date:  1992-01-24       Impact factor: 41.582

View more
  4 in total

Review 1.  Modulating nuclear receptor function: may the phos be with you.

Authors:  D Shao; M A Lazar
Journal:  J Clin Invest       Date:  1999-06       Impact factor: 14.808

2.  Activation of peroxisome proliferator-activated receptors (PPARs) by their ligands and protein kinase A activators.

Authors:  G Lazennec; L Canaple; D Saugy; W Wahli
Journal:  Mol Endocrinol       Date:  2000-12

3.  Multiple promoters direct the tissue-specific expression of novel N-terminal variant human vitamin D receptor gene transcripts.

Authors:  L A Crofts; M S Hancock; N A Morrison; J A Eisman
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

4.  The G115S mutation associated with maturity-onset diabetes of the young impairs hepatocyte nuclear factor 4alpha activities and introduces a PKA phosphorylation site in its DNA-binding domain.

Authors:  Bénédicte Oxombre; Mostafa Kouach; Ericka Moerman; Pierre Formstecher; Bernard Laine
Journal:  Biochem J       Date:  2004-11-01       Impact factor: 3.857

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.